21 results
8-K
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
27 Jul 23
Maravai LifeSciences Announces Completion of Planned CEO Leadership Transition
4:11pm
package he had while serving as President of Maravai’s Biologics Safety Testing segment. Mr. Martin ceased serving as President of Maravai’s Biologics
8-K
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
19 Oct 22
Departure of Directors or Certain Officers
4:05pm
compensation package, as previously disclosed in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission
10-Q
f8ltvw87wshv qchytf
12 May 21
Quarterly report
4:26pm
424B4
ctkrd6p yq347shsb
9 Apr 21
Prospectus supplement with pricing info
4:02pm
DRS
2pvb6 mf552txtepg9
25 Mar 21
Draft registration statement
12:00am
10-K
xr6giamqaog0utpl
22 Mar 21
Annual report
4:22pm
424B4
wfh y34olk8p06h
23 Nov 20
Prospectus supplement with pricing info
4:36pm
S-1
EX-10.15
6nemu3r1x 2wj3
29 Oct 20
IPO registration
5:04pm
S-1
9ffz sqvhoj
29 Oct 20
IPO registration
5:04pm
S-1
EX-10.17
cyytu9k3lvrc
29 Oct 20
IPO registration
5:04pm
DRS/A
snjrswq
23 Oct 20
Draft registration statement (amended)
12:00am
DRS/A
ah71pdk4oc4jf36
14 Oct 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.17
clgu41in
14 Oct 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.15
x5vbuv85x
14 Oct 20
Draft registration statement (amended)
12:00am